Evening Primrose Oil

What is Evening Primrose Oil?

Evening primrose oil (EPO) is extracted from the seeds of Oenothera biennis, a wildflower native to North America. It is one of the richest plant-based sources of gamma-linolenic acid (GLA), a conditionally essential omega-6 fatty acid that most people cannot synthesize efficiently from dietary linoleic acid alone. The oil has been used medicinally since the 1970s, initially for eczema and inflammatory conditions, and its clinical applications have expanded to include women's hormonal health.

How does Evening Primrose Oil work?

GLA from EPO is converted in the body to dihomo-gamma-linolenic acid (DGLA), which serves as the precursor to prostaglandin E1 (PGE1) — an eicosanoid with anti-inflammatory, vasodilatory, and platelet-inhibitory properties. Increased PGE1 activity may reduce the hormone-driven inflammation underlying PMS symptoms, breast tenderness, and skin barrier dysfunction. In women with mastalgia and PMS, research suggests that deficient GLA-to-DGLA conversion — possibly due to reduced delta-6-desaturase enzyme activity — contributes to symptoms, and supplemental GLA bypasses this enzymatic bottleneck.

What forms does Evening Primrose Oil come in?

Oral softgel capsules are the most clinically studied delivery form. Liquid oil is available for those who prefer to add it to food, though it is prone to oxidation and must be stored refrigerated and away from light. Topical formulations are used for skin conditions such as eczema and dry skin, but the evidence base for topical EPO is weaker than for oral supplementation. Some products combine EPO with borage oil (a higher-GLA source) to reduce the number of capsules needed.

Where it comes from:

Native Americans used the whole Oenothera biennis plant for various purposes, including poultices for bruising and skin disorders. Modern interest in the oil's therapeutic properties began in the 1970s when British researchers identified its GLA content and began investigating it for atopic eczema. The first commercial pharmaceutical-grade EPO product (Efamol) was introduced in the UK in the 1980s, where it held licensed drug status for mastalgia for a period before being reclassified as a supplement.

What does Evening Primrose Oil help with?

Evening primrose oil, or EPO, is cold-pressed from the seeds of a wild plant. The seeds are rich in GLA, an omega-6 fat. In lab work, GLA shifts the body toward fats that damp down swelling.

• Hot flashes after menopause
  Good evidence — one 56-person double-blind trial in the BMJ. In one trial of 56 women past menopause, EPO was tested against a dummy pill. Those on 4 x 500 mg a day had fewer and milder hot flashes over six weeks. Chenoy and colleagues published this in the BMJ in 1994.
  Evidence grade B · Traditional tier T1
• Joint pain and morning stiffness in rheumatoid arthritis
  Good evidence — one 40-person double-blind trial, modest effect. One 40-person trial tested 6 g of EPO a day for 12 months. People with rheumatoid arthritis reported less pain and less morning stiffness than those on a dummy pill, but the gain was small. Brzeski and colleagues published it in Annals of the Rheumatic Diseases in 1991.
  Evidence grade B · Traditional tier T1
• Breast pain that comes and goes with your cycle
  Early evidence — two Lancet trials with mixed results. Two trials in the Lancet looked at EPO for cyclic breast pain (Pashby 1981; Gateley 1992). EPO worked less well than the drugs bromocriptine and danazol. It caused far fewer side effects, so some UK guidelines of that time listed it first for mild or moderate pain.
  Evidence grade C · Traditional tier T1
• PMS mood swings, bloating and sore breasts
  Early evidence — several small trials of uneven quality, pooled in one 1990 review. A number of small trials have tested EPO for PMS. A review by Khoo and colleagues (1990, International Journal of Gynecology & Obstetrics) found real gains in mood symptoms. Trial quality varied and the groups were small, so the finding is not firm.
  Evidence grade C · Traditional tier T1
• Itchy, dry skin from atopic eczema
  Evidence doesn't support this — a 2013 Cochrane review of the trials found no clear benefit. A Cochrane review by Bamford and colleagues (2013) pooled the trials of oral EPO and borage oil for eczema. It found the evidence did not support either oil as a working treatment. Some people still report softer, less itchy skin, but the trials do not back that up.
  Evidence grade D · Traditional tier T1

What Evening Primrose Oil has not been shown to do

• A 2013 Cochrane review found oral EPO did not clearly help atopic eczema.
• In the Lancet trials it did not match bromocriptine or danazol for cyclic breast pain.
• It has not been shown to stand in for hormone or other proven care for severe menopause symptoms.
• In rheumatoid arthritis it was studied as an add-on, not as a swap for arthritis drugs.

How to read this:

Each use above has its own grade. A means steady results across human trials. B means at least one good human trial. C means small, early or mixed human work. D means the human evidence is weak or clashes. Insufficient means no human study at all. The grade sits with the use, not with the oil as a whole. This page lists options and what studies found. It is not advice, and it is not a promise that EPO will work for you. Talk to your own clinician before you start.

What can Evening Primrose Oil help prevent?

• Recurrence of cyclic mastalgia (ongoing supplementation may prevent symptom return between menstrual cycles based on the mastalgia RCT literature)

Which foods are rich in Evening Primrose Oil?

1. Borage seed oil: Contains approximately 20–26% GLA — significantly higher than EPO — making it the most concentrated natural food-based GLA source, though it is typically used as a supplement oil rather than a culinary staple.
2. Black currant seed oil: Contains approximately 15–20% GLA along with alpha-linolenic acid, providing a balanced omega fatty acid profile with meaningful GLA content comparable to high-quality EPO.
3. Hemp seeds and hemp seed oil: Contains GLA at lower concentrations (1–4%) but is widely available and provides a favorable omega-3 to omega-6 ratio alongside GLA, supporting anti-inflammatory pathways.
4. Spirulina: One of the few non-oil food sources containing meaningful GLA (approximately 1% of dry weight), making it a useful dietary contributor for those seeking GLA from whole foods.
5. Oats: Contain trace amounts of GLA and support delta-6-desaturase enzyme activity (which converts linoleic acid to GLA endogenously) through their zinc and magnesium content, indirectly supporting GLA status.

Practical Tips:

Evening primrose oil itself is not a common culinary food, but its active component GLA is found in several specialty seed oils. To support the same anti-inflammatory prostaglandin E1 pathway that EPO targets, emphasize foods rich in GLA (borage, black currant, hemp seed oil), ensure adequate zinc and magnesium intake (which cofactor the delta-6-desaturase enzyme), and reduce saturated fat and trans fat intake, which compete with GLA metabolism. Reducing arachidonic acid-rich foods (processed meats, conventional grain-fed animal products) may enhance EPO's anti-inflammatory effect.

What are the side effects of Evening Primrose Oil?

• Nausea and mild gastrointestinal upset (most common, particularly at higher doses)
• Loose stools or diarrhea
• Headache (reported in some trials)
• Bloating
• Theoretical increased bleeding risk (clinically significant mainly with concurrent anticoagulant use)
• Rare: lowered seizure threshold (primarily a concern with phenothiazine co-administration)

Good to know:

Evening primrose oil has a well-established safety record in clinical trials at doses up to 6–8 g/day for periods of 12 months. It is generally considered safe for most adults. The most common adverse effects are gastrointestinal and dose-dependent. It should be used with caution in people with seizure disorders, bleeding disorders, or those taking anticoagulant medications.

How much Evening Primrose Oil should you take?

• Recommended daily: Typical clinical doses range from 3,000–6,000 mg/day of EPO (providing approximately 240–480 mg GLA at 8% GLA content), taken in divided doses. For mastalgia and PMS, most trials used 3,000–4,000 mg/day. For RA, trials have used up to 6,000 mg/day. Check label GLA content rather than relying solely on total mg.
• Best time of day: Divide doses across meals (e.g., morning and evening with food). No strong evidence favoring a specific time of day.
• With or without food: Always take with food — fat-containing meals enhance GLA absorption and reduce gastrointestinal side effects.
• Time to effect: Minimum 4–6 weeks for initial effects; 8–12 weeks for full benefit assessment. Fatty acid membrane incorporation takes time.
• How long to take it: Most clinical trials have run for 3–12 months of continuous use. For cyclic conditions (PMS, mastalgia), some practitioners recommend taking EPO continuously rather than only in the luteal phase, as fatty acid repletion requires sustained supplementation. Long-term safety beyond 12 months is not well characterized in RCTs; periodic reassessment is reasonable.